Cargando…
Tumor-specific T cells signal tumor destruction via the lymphotoxin β receptor
BACKGROUND: Previously, we reported that adoptively transferred perforin k/o (PKO), and IFN-γ k/o (GKO), or perforin/IFN-γ double k/o (PKO/GKO) effector T cells mediated regression of B16BL6-D5 (D5) pulmonary metastases and showed that TNF receptor signaling played a critical role in mediating tumor...
Autores principales: | , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1838896/ https://www.ncbi.nlm.nih.gov/pubmed/17355640 http://dx.doi.org/10.1186/1479-5876-5-14 |
_version_ | 1782132835619962880 |
---|---|
author | Winter, Hauke van den Engel, Natasja K Poehlein, Christian H Hatz, Rudolf A Fox, Bernard A Hu, Hong-Ming |
author_facet | Winter, Hauke van den Engel, Natasja K Poehlein, Christian H Hatz, Rudolf A Fox, Bernard A Hu, Hong-Ming |
author_sort | Winter, Hauke |
collection | PubMed |
description | BACKGROUND: Previously, we reported that adoptively transferred perforin k/o (PKO), and IFN-γ k/o (GKO), or perforin/IFN-γ double k/o (PKO/GKO) effector T cells mediated regression of B16BL6-D5 (D5) pulmonary metastases and showed that TNF receptor signaling played a critical role in mediating tumor regression. In this report we investigated the role of lymphotoxin-α (LT-α) as a potential effector molecules of tumor-specific effector T cells. METHODS: Effector T cells were generated from tumor vaccine-draining lymph node (TVDLN) of wt, GKO, LT-α deficient (LKO), or PKO/GKO mice and tested for their ability to mediate regression of D5 pulmonary metastases in the presence or absence of LT-βR-Fc fusion protein or anti-IFN-γ antibody. Chemokine production by D5 tumor cells was determined by ELISA, RT-PCR and Chemotaxis assays. RESULTS: Stimulated effector T cells from wt, GKO, or PKO/GKO mice expressed ligands for LT-β receptor (LT-βR). D5 tumor cells were found to constitutively express the LT-βR. Administration of LT-βR-Fc fusion protein completely abrogated the therapeutic efficacy of GKO or PKO/GKO but not wt effector T cells (p < 0.05). Consistent with this observation, therapeutic efficacy of effector T cells deficient in LT-α, was greatly reduced when IFN-γ production was neutralized. While recombinant LT-α1β2 did not induce apoptosis of D5 tumor cells in vitro, it induced secretion of chemokines by D5 that promoted migration of macrophages. CONCLUSION: The contribution of LT-α expression by effector T cells to anti-tumor activity in vivo was not discernable when wt effector T cells were studied. However, the contribution of LT-β R signaling was identified for GKO or PKO/GKO effector T cells. Since LT-α does not directly induce killing of D5 tumor cells in vitro, but does stimulate D5 tumor cells to secrete chemokines, these data suggest a model where LT-α expression by tumor-specific effector T cells interacts via cross-linking of the LT-βR on tumor cells to induce secretion of chemokines that are chemotactic for macrophages. While the contribution of macrophages to tumor elimination in our system requires additional study, this model provides a possible explanation for the infiltration of inate effector cells that is seen coincident with tumor regression. |
format | Text |
id | pubmed-1838896 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2007 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-18388962007-03-29 Tumor-specific T cells signal tumor destruction via the lymphotoxin β receptor Winter, Hauke van den Engel, Natasja K Poehlein, Christian H Hatz, Rudolf A Fox, Bernard A Hu, Hong-Ming J Transl Med Research BACKGROUND: Previously, we reported that adoptively transferred perforin k/o (PKO), and IFN-γ k/o (GKO), or perforin/IFN-γ double k/o (PKO/GKO) effector T cells mediated regression of B16BL6-D5 (D5) pulmonary metastases and showed that TNF receptor signaling played a critical role in mediating tumor regression. In this report we investigated the role of lymphotoxin-α (LT-α) as a potential effector molecules of tumor-specific effector T cells. METHODS: Effector T cells were generated from tumor vaccine-draining lymph node (TVDLN) of wt, GKO, LT-α deficient (LKO), or PKO/GKO mice and tested for their ability to mediate regression of D5 pulmonary metastases in the presence or absence of LT-βR-Fc fusion protein or anti-IFN-γ antibody. Chemokine production by D5 tumor cells was determined by ELISA, RT-PCR and Chemotaxis assays. RESULTS: Stimulated effector T cells from wt, GKO, or PKO/GKO mice expressed ligands for LT-β receptor (LT-βR). D5 tumor cells were found to constitutively express the LT-βR. Administration of LT-βR-Fc fusion protein completely abrogated the therapeutic efficacy of GKO or PKO/GKO but not wt effector T cells (p < 0.05). Consistent with this observation, therapeutic efficacy of effector T cells deficient in LT-α, was greatly reduced when IFN-γ production was neutralized. While recombinant LT-α1β2 did not induce apoptosis of D5 tumor cells in vitro, it induced secretion of chemokines by D5 that promoted migration of macrophages. CONCLUSION: The contribution of LT-α expression by effector T cells to anti-tumor activity in vivo was not discernable when wt effector T cells were studied. However, the contribution of LT-β R signaling was identified for GKO or PKO/GKO effector T cells. Since LT-α does not directly induce killing of D5 tumor cells in vitro, but does stimulate D5 tumor cells to secrete chemokines, these data suggest a model where LT-α expression by tumor-specific effector T cells interacts via cross-linking of the LT-βR on tumor cells to induce secretion of chemokines that are chemotactic for macrophages. While the contribution of macrophages to tumor elimination in our system requires additional study, this model provides a possible explanation for the infiltration of inate effector cells that is seen coincident with tumor regression. BioMed Central 2007-03-13 /pmc/articles/PMC1838896/ /pubmed/17355640 http://dx.doi.org/10.1186/1479-5876-5-14 Text en Copyright © 2007 Winter et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Winter, Hauke van den Engel, Natasja K Poehlein, Christian H Hatz, Rudolf A Fox, Bernard A Hu, Hong-Ming Tumor-specific T cells signal tumor destruction via the lymphotoxin β receptor |
title | Tumor-specific T cells signal tumor destruction via the lymphotoxin β receptor |
title_full | Tumor-specific T cells signal tumor destruction via the lymphotoxin β receptor |
title_fullStr | Tumor-specific T cells signal tumor destruction via the lymphotoxin β receptor |
title_full_unstemmed | Tumor-specific T cells signal tumor destruction via the lymphotoxin β receptor |
title_short | Tumor-specific T cells signal tumor destruction via the lymphotoxin β receptor |
title_sort | tumor-specific t cells signal tumor destruction via the lymphotoxin β receptor |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1838896/ https://www.ncbi.nlm.nih.gov/pubmed/17355640 http://dx.doi.org/10.1186/1479-5876-5-14 |
work_keys_str_mv | AT winterhauke tumorspecifictcellssignaltumordestructionviathelymphotoxinbreceptor AT vandenengelnatasjak tumorspecifictcellssignaltumordestructionviathelymphotoxinbreceptor AT poehleinchristianh tumorspecifictcellssignaltumordestructionviathelymphotoxinbreceptor AT hatzrudolfa tumorspecifictcellssignaltumordestructionviathelymphotoxinbreceptor AT foxbernarda tumorspecifictcellssignaltumordestructionviathelymphotoxinbreceptor AT huhongming tumorspecifictcellssignaltumordestructionviathelymphotoxinbreceptor |